Coronary endothelial dysfunction is associated with inflammation and vasa vasorum proliferation in patients with early atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 11, 2014, Pages 2473-2477

  Choi, Byoung Joo ^a,b   Matsuo, Yoshiki ^a   Aoki, Tatsuo ^a   Kwon, Taek Geun ^a   Prasad, Abhiram ^a   Gulati, Rajiv ^a   Lennon, Ryan J ^a   Lerman, Lilach O ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Coronary disease; Inflammation; Optical coherence tomography

Indexed keywords

ACETYLCHOLINE; VASODILATOR AGENT;

ADULT; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG RESPONSE; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; MACROPHAGE; MALE; MICROVASCULATURE; OPTICAL COHERENCE TOMOGRAPHY; VASA VASORUM; AGED; CELL COUNT; CELL PROLIFERATION; COMPARATIVE STUDY; CORONARY BLOOD VESSEL; DRUG EFFECTS; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; AGED; CELL COUNT; CELL PROLIFERATION; CORONARY ARTERY DISEASE; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; VASA VASORUM; VASODILATOR AGENTS;

EID: 84911913918     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304445     Document Type: Article

References (33)

1. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Creager MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B-74B .
2. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363-368.
3. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lü scher TF, Shechter M, Taddei S, Vita JA, Lerman A. The assessment of endothelial function: from research into clinical practice. Circulation. 2012;126:753-767.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
5. Yoon MH, Reriani M, Mario G, Rihal C, Gulati R, Lennon R, Tilford JM, L erman LO, Lerman A. Long-term endothelin receptor antagonism attenuates coronary plaque progression in patients with early atherosclerosis. Int J Cardiol. 2013;168:1316-1321.
6. Quyyumi AA, Cannon R O III, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation. 1992;86:1864-1871.
7. Zeiher AM, Drexler H, Saurbie r B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
8. Nishimura RA, L erman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr, Tajik AJ. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Co ll Cardiol. 1995;26:41-49.
9. Herrmann J, Lerman LO, Rodriguez-Porcel M, Holmes DR Jr, Richardson DM, Ritman EL, Lerman A. Coronary vasa vasorum neovascularization precedes epicardial endot helial dysfunction in experimental hypercholesterolemia. Cardiovasc Res. 2001;51:762-766.
10. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285-1295.
11. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
12. Lavi S, Bae JH, Rihal CS, Pr asad A, Barsness GW, Lennon RJ, Holmes DR Jr, Lerman A. Segmental coronary endothelial dysfunction in patients with minimal atherosclerosis is associated with necrotic core plaques. Heart. 2009;95:1525-1530.
13. Choi BJ, Prasad A, Gulati R, Best PJ, Lennon RJ, Barsness GW, Lerman LO, Lerman A. Coronary endothelial dysfunction in patients with early coronary artery disease is associated with the increase in intr avascular lipid core plaque. Eur Heart J. 2013;34:2047-2054.
14. Tearney GJ,Yabushita H,Houser SL,Aretz HT,Jang IK,Schlendorf KH,Kauffman CR,Shishkov M,Halpern EF,Bouma BE. Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. 2003;107:113-119.
15. MacNeill BD, Jang IK, Bouma BE, Iftimia N, Takano M, Yabushita H, Shishkov M, Kauffman CR, Houser SL, Aretz HT, DeJoseph D, Halpern EF, Tearney GJ. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery d isease. J Am Coll Cardiol. 2004;44:972-979.
16. Kitabata H, Tanaka A, Kubo T, et al. Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patien ts with coronary artery disease. Am J Cardiol. 2010;105:1673-1678.
17. Uemura S, Ishigami K, Soeda T, Okayama S, Sung JH, Nakagawa H, Somekawa S, Takeda Y, Kawata H, Horii M, Saito Y. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J. 2012;33:78-85.
18. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-1143.
19. Kashiwagi M, Kitabata H, Ozaki Y, Imanishi T, Akasaka T. Fatty streak assessed by opt ical coherence tomography: early atherosclerosis detection. Eur Heart J Cardiovasc Imaging. 2013;14:109.
20. Steinberg D. Lipoproteins and the pathogenesis of atherosclerosis. Circulation. 1987;76:508-514.
21. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
22. Yang EH, McConnell JP, Lennon RJ, Barsness GW, Pumper G, Hartman SJ , Rihal CS, Lerman LO, Lerman A. Lipoprotein-associated phospholipase A2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol. 2006;26:106-111.
23. Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, Lerman LO, Lerman A. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary a therosclerosis and endothelial dysfunction in humans. Circulation. 2007;115:2715-2721.
24. Williams JK, Heistad DD. Structure and function of vasa vasorum. Trends Cardiovasc Med. 1996;6:53-57.
25. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation. 2006; 113:2245-2252.
26. Heistad DD, Armstrong ML. Blood flow through vasa vasorum of coronary arteries in atherosclerotic monkeys. Arteriosclerosis. 1986;6:326-331.
27. Kwon HM, Sangiorgi G, Ritman E L, McKenna C, Holmes DR Jr, Schwartz RS, Lerman A. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clin Invest. 1998;101:1551-1556.
28. Wilson SH, Herrmann J, Lerman LO, Holmes DR Jr, Napoli C, Ritman EL, Lerman A. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation. 2002;105:415-418.
29. Herrmann J, Lerman A. Atherosclerosis in the back yard. J Am Coll Cardiol. 2007;49:2102-2104.
30. Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25:2054-20 61.
31. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature. 1977;269:804-806.
32. Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012;5:433-440.
33. Tearney GJ, Regar E, Akasaka T, et al.; International Working Group for Intra vascular Optical Coherence Tomography (IWG-IVOCT). Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tom ography Standardization and Validation. J Am Coll Cardiol. 2012;59:1058-1072.